Related Experiment Video
Updated: Mar 8, 2026

06:14
Translational Rabbit Model of Chronic Cardiac Pacing
Published on: January 6, 2023
3.2K
Permanent pacemaker implantation in octogenarians with unexplained syncope and positive electrophysiologic testing
Georgios Giannopoulos1, Charalampos Kossyvakis2, Vasiliki Panagopoulou3
1Cardiology Department, Athens General Hospital "G. Gennimatas," Athens, Greece; 2nd Department of Cardiology, National and Kapodistrean University of Athens Medical School, Attikon University Hospital, Athens, Greece.
Heart Rhythm
|January 17, 2017
Summary
Permanent pacemaker implantation in elderly patients with unexplained syncope and positive electrophysiologic testing (EPT) significantly improves syncope-free survival and reduces mortality. This intervention offers a clear benefit in selected older adults.
Area of Science:
- Cardiology
- Geriatrics
- Electrophysiology
Background:
- Syncope is a prevalent issue in the elderly population.
- Permanent pacemaker implantation is a therapeutic option for syncope with a confirmed bradycardic cause.
- The efficacy of pacing for unexplained syncope without a clear bradycardic association, particularly in older adults, remains uncertain.
Purpose of the Study:
- To investigate the impact of pacemaker implantation on syncope-free mortality in patients aged 80 years and above presenting with unexplained syncope and positive invasive electrophysiologic testing (EPT).
Main Methods:
- An observational study design was employed.
- Positive EPT was defined by specific criteria including corrected sinus node recovery time (>525 ms), basic HV interval (>55 ms), infra-Hisian block, or second-degree atrioventricular block during decremental atrial pacing (>400 ms).
- Kaplan-Meier analysis was used to compare outcomes between patients with and without pacemakers.
Main Results:
- Out of 2435 screened patients, 228 were eligible, with 145 receiving pacemakers.
- Pacemaker recipients experienced a longer time to syncope or death (50.1 months) compared to non-recipients (37.8 months) (P = .001).
- The 4-year incidence of syncope was significantly lower (12% vs. 44%, P < .001) and all-cause mortality was also reduced (41% vs. 56%, P = .023) in the pacemaker group.
Conclusions:
- Pacemaker implantation is independently associated with improved syncope-free survival in elderly patients with unexplained syncope and evidence of sinus node dysfunction or atrioventricular conduction abnormalities on EPT.
- The study demonstrated significant benefits in both syncope recurrence and overall mortality.
- These findings support the use of pacing in carefully selected elderly patients with unexplained syncope and positive EPT results.

